| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9beae656a28ded212cf39a4d26f76bfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eca3764daf7c19cf873fb5f494b27c0e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2013-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d30b384508e2547d98ef2a97f3a9ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a39b773ab60e1602c797adbb7a9a0bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_202882a78399ca705d36130a26765c45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f3e89b9d6b30e6811992a9ea7bcdf49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02ad9af6e2bfd2502fac31ae22741491
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d70062796db6c28ca7fbed59482d9c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d9fe897c3602fc1caa9be3556482b53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31d13a6b1dc47bf23b7ef8d6570bb46a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db565850ac774f5cf04ca505d37f9421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acd2a1540eddb15b482067fe54783cba |
| publicationDate |
2013-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013160498-A1 |
| titleOfInvention |
Human anti-her2 monoclonal antibody |
| abstract |
The present invention relates to a human monoclonal antibody that recognizes the extracellular domain of human epidermal growth factor receptor 2 (HER2) and is produced in human embryonic retinal cells. The present invention also relates to the use of said antibody to measure the level of expression of HER2 and to prepare a drug for treating neoplastic disorders involving overexpression of HER2. |
| priorityDate |
2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |